Growth Metrics

Glaukos (GKOS) Cash from Operations Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Glaukos 6.00 Bn 5.90 Bn 117.23 Mn 32.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 32.37%
Dec 31, 2025 1,247.53%
Sep 30, 2025 -5.26%
Jun 30, 2025 137.99%
Mar 31, 2025 45.32%
Dec 31, 2024 104.75%
Sep 30, 2024 -17.36%
Jun 30, 2024 -125.08%
Mar 31, 2024 -10.10%
Dec 31, 2023 -157.86%
Sep 30, 2023 69.19%
Jun 30, 2023 33.14%
Mar 31, 2023 -414.75%
Dec 31, 2022 11.07%
Sep 30, 2022 -249.04%
Jun 30, 2022 -265.15%
Mar 31, 2022 133.94%
Dec 31, 2021 -143.86%
Sep 30, 2021 285.89%
Jun 30, 2021 167.66%
Mar 31, 2021 131.90%
Dec 31, 2020 353.02%
Sep 30, 2020 -220.28%
Jun 30, 2020 -265.45%
Mar 31, 2020 -6,397.60%
Dec 31, 2019 -124.47%
Sep 30, 2019 -168.50%
Jun 30, 2019 72.56%
Mar 31, 2019 103.22%
Dec 31, 2018 37.44%
Sep 30, 2018 -37.61%
Jun 30, 2018 -11.27%
Mar 31, 2018 -377.39%
Dec 31, 2017 280.17%
Sep 30, 2017 77.93%
Jun 30, 2017 -28.60%
Mar 31, 2017 348.24%
Dec 31, 2016 675.09%
Sep 30, 2016 805.39%
Jun 30, 2016 820.64%
Mar 31, 2016 9.29%
Dec 31, 2015 61.74%
Sep 30, 2015 -20.82%
Jun 30, 2015 -316.92%